Is Aristada Long-Acting?
Yes, Aristada (aripiprazole lauroxil) is a long-acting injectable antipsychotic designed for extended release.[1] It delivers medication over weeks or months after a single intramuscular injection, reducing the need for daily pills in treating schizophrenia.
How Long Does Aristada Last?
Aristada comes in formulations lasting 4, 6, or 8 weeks per dose:
- Aristada 441 mg or 662 mg: Every 4 weeks.
- Aristada 882 mg: Every 6 weeks.
- Aristada Initio 675 mg: One-time initiation dose, paired with a longer Aristada dose.[1][2]
This contrasts with short-acting oral aripiprazole, which requires daily dosing.
Why Use Long-Acting Over Oral Antipsychotics?
Long-acting injectables like Aristada improve adherence—up to 50% of schizophrenia patients skip daily meds, risking relapse.[3] A single injection ensures steady drug levels, with peak effects building over days and sustained release via conversion to active aripiprazole in the body.
Who Makes Aristada and What's the Dosing Schedule?
Alkermes plc manufactures Aristada, approved by the FDA in 2015.[1] Standard regimen starts with Aristada Initio on day 1, oral aripiprazole days 1-21 for overlap, then monthly or extended injections. Doses adjust based on patient response and tolerability.
Common Side Effects Patients Report
Injection-site pain, akathisia (restlessness), weight gain, and sedation occur most often.[1] Long-acting nature means effects persist if issues arise, so monitoring is key during the first few months.
How Does Aristada Compare to Other Long-Acting Injectables?
| Drug | Active Ingredient | Duration | Key Difference |
|------|-------------------|----------|---------------|
| Aristada | Aripiprazole lauroxil | 4-8 weeks | Prodrug converts slowly in tissue [1] |
| Abilify Maintena | Aripiprazole | 4 weeks | Direct release, no prodrug step [4] |
| Invega Sustenna | Paliperidone palmitate | 4 weeks | Targets different receptor profile [5] |
| Invega Trinza | Paliperidone palmitate | 3 months | Longest interval option [5] |
Aristada suits patients needing flexible monthly dosing without daily orals long-term.
When Do Aristada Patents Expire?
Core patents protect Aristada until around 2030, with some formulation patents extending to 2033.[6] No generics yet; Alkermes defends against challenges.
[1]: FDA Label for Aristada
[2]: Alkermes Aristada Site
[3]: JAMA Psychiatry Study on Adherence
[4]: FDA Label for Abilify Maintena
[5]: FDA Label for Invega Products
[6]: DrugPatentWatch.com - Aristada Patents